Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Glycemic durability of monotherapy for diabetes.

Garg R.

N Engl J Med. 2007 Mar 29;356(13):1379; author reply 1380. No abstract available.

PMID:
17402165
2.

Effects of rosiglitazone, glyburide, and metformin on ╬▓-cell function and insulin sensitivity in ADOPT.

Kahn SE, Lachin JM, Zinman B, Haffner SM, Aftring RP, Paul G, Kravitz BG, Herman WH, Viberti G, Holman RR; ADOPT Study Group.

Diabetes. 2011 May;60(5):1552-60. doi: 10.2337/db10-1392. Epub 2011 Mar 17.

3.

Choosing first-line therapy for management of type 2 diabetes.

Graber MA, Darby-Stewart A, Dachs R.

Am Fam Physician. 2008 Jan 1;77(1):16-7. No abstract available.

4.

New therapeutic options: management strategies to optimize glycemic control.

Sisam DA.

J Am Osteopath Assoc. 2011 Apr;111(4):300; author reply 300. No abstract available.

PMID:
21562302
5.

Thiazolidinediones for initial treatment of type 2 diabetes?

Nathan DM.

N Engl J Med. 2006 Dec 7;355(23):2477-80. Epub 2006 Dec 4. No abstract available.

7.

Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?

Standl E, Schnell O.

Diabetes Care. 2008 Feb;31 Suppl 2:S136-9. doi: 10.2337/dc08-s234. No abstract available.

PMID:
18227474
8.

Glycemic durability of monotherapy for diabetes.

Rathmann W, Kostev K, Haastert B.

N Engl J Med. 2007 Mar 29;356(13):1378-9; author reply 1380. No abstract available.

9.

[ADOPT study: Reevaluation of antidiabetic drugs. Control of diabetes].

[No authors listed]

MMW Fortschr Med. 2007 Apr 12;149(15):52-3. German. No abstract available.

PMID:
17668778
10.

[Status of glitazones in treatment of type 2 diabetes mellitus].

Willeke A.

Internist (Berl). 2007 Jul;48(7):749; author reply 749-50. German. No abstract available.

PMID:
17571246
11.

[Consulting Prof. Dr. Stephan Matthaei. Quakenbr├╝ck diabetes center. Prescription relevant conclusions].

Matthaei S.

MMW Fortschr Med. 2007 Apr 12;149(15):53. German. No abstract available.

PMID:
17668779
12.

[ADOPT study. Glitazone controls diabetes progression].

Einecke D.

MMW Fortschr Med. 2007 Jan;149(1-2):10, 12, 14. German. No abstract available.

PMID:
17619358
13.

Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.

Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, Rawdaree P, Plengvidhya N, Leelawatana R, Bunnag P, Pratipanawatr T, Krittiyawong S, Suwanwalaikorn S, Deerochanawong C, Chetthakul T, Ngarmukos C, Komoltri C.

J Med Assoc Thai. 2006 Aug;89 Suppl 1:S66-71.

PMID:
17715836
15.
16.

Advances in oral therapy for type 2 diabetes.

Davis SN.

Postgrad Med. 2000 May 15;107(6 Suppl Key):16-20. doi: 10.3810/pgm.5.15.2000.suppl4.23. Review.

PMID:
19667506
17.

Glyburide/metformin (Glucovance) for type 2 diabetes.

[No authors listed]

Med Lett Drugs Ther. 2000 Nov 13;42(1092):105-6. No abstract available.

PMID:
11077467
19.

Treatment of type 2 diabetes with combined therapy: what are the pros and cons?

Massi-Benedetti M, Orsini-Federici M.

Diabetes Care. 2008 Feb;31 Suppl 2:S131-5. doi: 10.2337/dc08-s233. Review.

PMID:
18227473
20.

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

Jermendy G; Hungarian RECAP Group, Erdesz D, Nagy L, Yin D, Phatak H, Karve S, Engel S, Balkrishnan R.

Health Qual Life Outcomes. 2008 Oct 31;6:88. doi: 10.1186/1477-7525-6-88.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk